ArticleBMJ open2025

Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.

David Gleeson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.